1. 2019
  2. Published

    Extended-spectrum β-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing study

    Day, M. J., Hopkins, K. L., Wareham, D., Toleman, M. A., Elviss, N., Randall, L., Teale, C., Cleary, P., Wiuff, C., Doumith, M., Ellington, M. J., Woodford, N. & Livermore, D., Dec 2019, In : The Lancet Infectious Diseases. 19, 12, p. 1325-1335 11 p.

    Research output: Contribution to journalArticle

  3. Published

    Potentiation of imipenem by relebactam for Pseudomonas aeruginosa from bacteraemia and respiratory infections

    BSAC Resistance Surveillance Standing Committee & Livermore, D. M., Jul 2019, In : Journal of Antimicrobial Chemotherapy. 74, 7, p. 1940-1944

    Research output: Contribution to journalArticle

  4. Published

    Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infection

    Charalampous, T., Kay, G., Richardson, H., Aydin, A., Baldan, R., Jeanes, C., Rae, D., Grundy, S., Turner, D. J., Wain, J., Leggett, R. M., Livermore, D. & O'Grady, J., 24 Jun 2019, In : Nature Biotechnology. 37, p. 783–792

    Research output: Contribution to journalArticle

  5. Published

    Compassionate use of cefiderocol as adjunctive treatment of native aortic valve endocarditis due to XDR-Pseudomonas aeruginosa

    Edgeworth, J. D., Merante, D., Patel, S., Young, C., Jones, P., Vithlani, S., Wyncoll, D., Roberts, P., Jones, A., Nagata, T. D., Ariyasu, M., Livermore, D. M. & Beale, R., 1 Jun 2019, In : Clinical Infectious Diseases. 68, 11, p. 1932–1934

    Research output: Contribution to journalArticle

  6. Published

    Doxycycline in UK guidelines for hospital-acquired pneumonia: where is the evidence base?—authors’ response

    Russell, A. H., Horner, C., Livermore, D. M. & Macgowan, A. P., Jun 2019, In : Journal of Antimicrobial Chemotherapy. 74, 6, p. 1767-1767

    Research output: Contribution to journalLetter

  7. Published

    Activity of nacubactam (RG6080/OP0595) combinations against metallo-β-lactamase (MBL)-producing Enterobacteriaceae

    Mushtaq, S., Vickers, A., Woodford, N., Haldimann, A. & Livermore, D., Apr 2019, In : Journal of Antimicrobial Chemotherapy. 74, 4, p. 953–960

    Research output: Contribution to journalArticle

  8. Published

    Evaluation of multiplex tandem PCR (MT-PCR) assays for the detection of bacterial resistance genes among Enterobacteriaceae in clinical urines

    Schmidt, K., Stanley, K. K., Hale, R., Smith, L., Wain, J., O'Grady, J. & Livermore, D. M., 1 Feb 2019, In : Journal of Antimicrobial Chemotherapy. 74, 2, p. 349–356

    Research output: Contribution to journalArticle

  9. Published

    OXA-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producing Escherichia coli

    Livermore, D. M., Day, M., Cleary, P., Hopkins, K. L., Toleman, M. A., Wareham, D. W., Wiuff, C., Doumith, M. & Woodford, N., 1 Feb 2019, In : Journal of Antimicrobial Chemotherapy. 74, 2, p. 326–333

    Research output: Contribution to journalArticle

  10. 2018
  11. Published

    Selection of mutants with resistance or diminished susceptibility to ceftazidime/avibactam from ESBL- and AmpC- producing Enterobacteriaceae

    Livermore, D. M., Mushtaq, S., Doumith, M., Jamrozy, D., Nichols, W. W. & Woodford, N., 1 Dec 2018, In : Journal of Antimicrobial Chemotherapy. 73, 12, p. 3336–3345

    Research output: Contribution to journalArticle

  12. Published

    The 2018 Garrod Lecture: Preparing for the Black Swans of Resistance

    Livermore, D., 1 Nov 2018, In : Journal of Antimicrobial Chemotherapy. 73, 11, p. 2907–2915

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 ...26 Next

ID: 49723